MeSH term
Frequency | Condition_Probility | Amino Acid Sequence | 13 | 0.0 |
Animals | 12 | 0.0 |
Cell Line | 10 | 0.0 |
Humans | 35 | 0.0 |
Interferon Type I/*metabolism | 2 | 12.0 |
Ligands | 5 | 0.0 |
Mice | 4 | 0.0 |
Models, Molecular | 2 | 0.0 |
Molecular Sequence Data | 14 | 0.0 |
Protein Binding/genetics | 2 | 0.0 |
Protein Structure, Tertiary/genetics | 2 | 0.0 |
Research Support, Non-U.S. Gov't | 24 | 0.0 |
Sequence Homology, Amino Acid | 6 | 0.0 |
Transfection | 5 | 0.0 |
Binding Sites | 7 | 0.0 |
Interferon-alpha/*metabolism | 3 | 13.0 |
Nuclear Magnetic Resonance, Biomolecular | 2 | 1.0 |
Receptors, Interferon/chemistry/genetics/*metabolism | 3 | 37.0 |
Research Support, U.S. Gov't, P.H.S. | 16 | 0.0 |
Genetic Complementation Test | 2 | 0.0 |
Mutagenesis, Site-Directed | 4 | 0.0 |
Phosphorylation | 3 | 0.0 |
Protein Binding | 4 | 0.0 |
Protein Structure, Tertiary | 3 | 0.0 |
Recombinant Proteins/metabolism | 2 | 0.0 |
*Signal Transduction | 2 | 0.0 |
Tumor Cells, Cultured | 5 | 0.0 |
Comparative Study | 4 | 0.0 |
Interferons/metabolism | 2 | 8.0 |
Receptors, Interferon/*metabolism | 7 | 25.0 |
Time Factors | 2 | 0.0 |
Base Sequence | 4 | 0.0 |
Cattle | 4 | 0.0 |
Cloning, Molecular | 4 | 0.0 |
DNA-Binding Proteins/metabolism | 2 | 0.0 |
Sheep | 2 | 0.0 |
Solubility | 2 | 0.0 |
Trans-Activators/metabolism | 2 | 0.0 |
Adult | 6 | 0.0 |
Aged | 3 | 0.0 |
Female | 7 | 0.0 |
Male | 6 | 0.0 |
Middle Aged | 6 | 0.0 |
Protein Conformation | 2 | 0.0 |
Polymerase Chain Reaction | 4 | 0.0 |
Receptors, Interferon/genetics/*metabolism | 3 | 50.0 |
Interferon Alfa-2b/*therapeutic use | 2 | 5.0 |
Liver/*metabolism | 4 | 0.0 |
RNA, Viral/blood | 2 | 0.0 |
COS Cells | 2 | 0.0 |
Protein-Tyrosine Kinase/metabolism | 3 | 0.0 |
Signal Transduction | 3 | 0.0 |
Antiviral Agents/metabolism | 2 | 22.0 |
Cell Division | 2 | 0.0 |
Kinetics | 2 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 2 | 0.0 |
Structure-Activity Relationship | 4 | 0.0 |
Interferon-alpha/pharmacology | 4 | 4.0 |
DNA Mutational Analysis | 2 | 0.0 |
Chromatography, Gel | 2 | 0.0 |
Macromolecular Substances | 2 | 0.0 |
Receptors, Interferon/*genetics | 3 | 20.0 |
Sequence Alignment | 2 | 0.0 |
Mutation | 3 | 0.0 |
Interferon-beta/pharmacology | 2 | 4.0 |
Immunoblotting | 2 | 0.0 |
Gene Expression | 2 | 0.0 |
